NCT06431204

Brief Summary

The objective of this study is to examine the predictive capability of the Obstetric comorbidity index in the identification of severe maternal morbidity associated with postpartum hemorrhage in patients undergoing cesarean delivery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
583

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 17, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 28, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

July 13, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 26, 2025

Completed
Last Updated

October 2, 2025

Status Verified

September 1, 2025

Enrollment Period

1.2 years

First QC Date

May 17, 2024

Last Update Submit

September 28, 2025

Conditions

Keywords

cesarean sectionpostpartum hemorrhagematernal morbidityobstetrics comorbidity index

Outcome Measures

Primary Outcomes (1)

  • The prediction of severe maternal morbidity using obstetric comorbidity index

    The prediction of severe maternal morbidity using obstetric comorbidity index presented in C-statistic (AUC of ROC)

    in 72 hours after cesarean delivery

Secondary Outcomes (7)

  • Rate of blood transfusion

    in 72 hours after cesarean delivery

  • Quantity of postpartum hemorrhage

    in 24 hours after cesarean delivery

  • Cause of postpartum hemorrhage

    in 24 hours after cesarean delivery

  • Rate of ICU admission

    in 24 hours after cesarean delivery

  • Rate of Postoperative complications

    in 72 hours after cesarean delivery

  • +2 more secondary outcomes

Study Arms (2)

Patients with postpartum hemorrhage with severe maternal morbidity

Patients with either one of severe maternal morbidity (severe hemorrhage, hypertension/neurologic, renal, sepsis, pulmonary, cardiac, intensive care unit, and anesthesia complications)

Other: Obstetric comorbidity index

Patients with postpartum hemorrhage without severe maternal morbidity

Patients without the severe maternal morbidity conditions

Other: Obstetric comorbidity index

Interventions

Obstetric comorbidity index score

Patients with postpartum hemorrhage with severe maternal morbidityPatients with postpartum hemorrhage without severe maternal morbidity

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The chart of patients who underwent cesarean delivery with the diagnosis of postpartum hemorrhage (bleeding \>, = 1,000 ml) and gestational age of more than 24 weeks.

You may qualify if:

  • The patients underwent cesarean delivery with the diagnosis of postpartum hemorrhage (ICD-10 coding O72.1)

You may not qualify if:

  • Cesarean delivery at less than 24 weeks of gestation
  • A patient chart that does not contain primary outcome data eg. absence of anesthetic record
  • Blood loss less than 1,000 ml in the first 24 hours postpartum

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine Siriraj Hospital

Bangkok, 10700, Thailand

Location

MeSH Terms

Conditions

Postpartum Hemorrhage

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPuerperal DisordersUterine HemorrhageHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Patchareya Nivatpumin, M.D.

    Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok THAILAND

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 17, 2024

First Posted

May 28, 2024

Study Start

July 13, 2024

Primary Completion

September 26, 2025

Study Completion

September 26, 2025

Last Updated

October 2, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

The investigators may balance the potential benefits and risks for each request and then provide the data that could be shared, together with the permission from the hospital director.

Locations